Efficiency and Safety in Endotoxin Testing

We understand during this time releasing your product quickly is more important than ever. We’re here to support you in delivering your products faster while keeping your patients safe with rapid endotoxin testing.

MS-000814

QC lab technician performing an endotoxin test on an Endosafe nexgen-PTS utilizing cartridge technology

Endosafe® Rapid Testing Technology

Providing efficiency and safety in endotoxin testing with Endosafe® cartridge technology

  • Endotoxin testing results in as little as 15 minutes 
  • Pre-loaded cartridges with all of the reagents required to perform a LAL test, eliminating preparation of multiple reagents and reducing the opportunity for technician error 
  • FDA-licensed Endosafe® LAL cartridges are a kinetic chromogenic LAL method as specified in the EP/USP and JP 

Contact Us


Endosafe lal manufacturing gowned technician working with pipette in flow hood

The Reality of Recombinant Endotoxin Technologies

In late 2019, we presented our initial LAL and recombinant study data from global pharmaceutical organizations’ water samples. After a careful analysis of the data, we conducted a second, larger study with hundreds of global water samples evaluating the ruggedness, repeatability, and specificity of commercially available recombinant factor C products, as well as our own recombinant product in development, against a large panel of endotoxins.

View our webinar to explore these results and learn where recombinant products stacked up against LAL when it comes specificity and non-inferiority.

Watch the Webinar


Endosafe lal manufacturing gowned technician

The Criticality of Detecting Relevant Endotoxins in Global Pharmaceutical Water Samples

Accurate endotoxin quantification depends on the specificity of the method to detect all naturally occurring and relevant Gram-negative bacterial endotoxins. In this session, we will present study data from a global sampling of pharmaceutical pre-treatment waters. This study identifies the culturable microbes colonizing pre-treatment waters. More importantly, the presented data demonstrates the criticality of ensuring specificity and non-inferiority when testing relevant contaminated pharmaceutical water samples with both LAL and alternative testing methods. View our ePoster to explore these results and learn where recombinant products stacked up against LAL when it comes specificity and non-inferiority.

View our webinar to explore these results and learn where recombinant products stacked up against LAL when it comes specificity and non-inferiority.

View ePoster